Table III.
Follow‐Up Brachial Artery Measurements in Both Study Groups at Baseline and at Peak Hyperemia
| statin group (n=30) | placebo group (n=30) | P value | |
|---|---|---|---|
| Brachial artery diameter | |||
| Baseline, mm | 3.87±0.74 | 3.79±0.46 | .884 |
| Hyperemic, mm | 4.49±0.69 | 4.33±0.62 | .405 |
| Percent increase, % | 18.3 | 13.2 | .015a |
| Brachial artery flow velocity | |||
| Baseline, cm/s | 70.6±18.2 | 58.2±20.8 | .033a |
| Hyperemic, cm/s | 74.5±20.3 | 63.8±20.7 | .091 |
| Percent increase, % | 10.9 | 10.1 | .724 |
Continuous variables are presented as mean ± standard deviation. aSignificant P value.